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Basic fibroblast growth factor is a morphogenic modulator in kidney
vessel development. During kidney organogenesis the development of
renal vessels must be synchronized with the maturation of nephrons and
the collecting duct system. Several reports showed that hormones and
mitogenic peptides as basic fibroblast growth factor (bFGF) or vascular
endothelial growth factor (VEGF) are involved in this regulatory process.
It is a known fact that bFGF receptors are expressed by differentiating
tubular epithelium and mesenchyme, but little information is available
about the function of bFGF in kidney organogenesis. The role of bFGF
during kidney development was investigated using an organotypic culture
system and immunohistological techniques. Renal cortex explants were
prepared from the kidneys of neonatal rabbits with a microsurgical
method, retaining the natural tissue composition. The explants were
cultured serum free under continuous medium perfusion. Our results
indicate a new and unexpected role of bFGF during the differentiation
process. When bFGF alone was applied, vessels could no longer be
detected. The inhibitory influence of bFGF could be overcome by addition
of VEGF or hormones such as retinoic acid and aldosterone/vitamin D3.
The combination of these factors with bFGF resulted in the expression of
small vessel-like structures. We conclude that bFGF has a morphogenic
rather than a mitogenic function during kidney vessel development.
The development of vessels may depend on a number of very
different mechanisms. Whether new capillaries are formed by
sprouting from vessels, by the conversion from mesenchymal to
endothelial cells or by the insertion of new walls in existing vessels
depends on the organ and its developmental stage as well as on a
large number of regulatory molecules [1–3]. The requirements for
the different mechanisms of vessel formation are basically very
similar; however, all of them depend on a partial remodeling of
the extracellular matrix, endothelial cell proliferation, cell migra-
tion and cell differentiation. In every case, the sequence of these
steps has to be initiated, coordinated and finally terminated.
Numerous soluble factors have been described that stimulate
the proteolytic degradation of the extracellular matrix [4] or the
synthesis of new matrix material [5–8]. These factors may also
induce endothelial proliferation and migration [9–12]. Mitogens
and chemoattractants stimulating endothelial cells are synthesized
by a number of different cells [1, 13, 14]. Many of these substances
are small peptides like vascular endothelial growth factor
(VEGF), which acts on endothelial cells with high specificity [15,
16], or as basic fibroblast growth factor (bFGF), which possess a
low endothelial specificity [14].
Hormones such as retinoic acid or vitamin D3 have been known
for many years for their ability to induce differentiation [17, 18].
First indications of the vital role of retinoic acid in kidney
organogenesis came from feeding experiments with pregnant
animals [19]. These results were confirmed recently when kidney
agenesis or malformations were observed in retinoic acid receptor
deficient transgenic mice [20]. However, retinoic acid receptors
could not yet be detected within the embryonic kidney. In
contrast, aldosterone and vitamin D3 receptors are expressed in
large amounts by the cells of the developing collecting duct system
[21, 22]. Furthermore, the vitamin D receptor was found in
organotypically cultured mouse metanephroi [23]. Correspond-
ingly, a stimulating activity of aldosterone on the differentiation of
collecting duct epithelium was observed [24]. Otherwise, the
physiological function of vitamin D3 in the collecting duct epithe-
lium at this stage of kidney development is still unknown.
In this study a tissue culture system was used to investigate
whether hormones and peptide growth factors act directly on
renal cells during kidney vessel development. The nephrogenic
zone of the kidney of neonatal rabbits was microsurgically pre-
pared [25] and cultured for extended periods. Proteases were not
applied. With this method, both the complex cellular composition
of the tissue and its extracellular matrix remained unchanged. The
tissue pieces were cultured under serum free conditions with
continuous medium perfusion. The culture medium was supple-
mented with defined concentrations of bFGF, VEGF and differ-
ent hormones to analyze the modulating effect of these molecules
on the development of the renal vascular network.
METHODS
Tissue culture
Tissue explants were prepared from kidneys of one- to three-
day-old rabbits. The animals were killed by cervical dislocation,
and the organs were removed immediately. The capsula fibrosa
was stripped off under sterile conditions [25]. The nephrogenic
zone, composed of collecting duct ampullae, mesenchymal cells,
endothelium and nephrons in different developmental stages,
remained attached to the fibrous organ capsule.
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The explants were mounted in tissue carriers and inserted into
perfusion containers ([24]; Minucell and Minutissue, Bad Abbach,
Germany) that were placed on a warming plate (37°C; Medax,
Kiel, Germany). The tissue was cultured for up to 13 days under
continuous medium flow. Fresh culture medium was pumped
through the chamber at a flow rate of 1 ml/hr. Experiments were
conducted with IMDM culture medium (Gibco BRL-Life Tech-
nologies, Eggenstein, Germany), supplemented with 0.1 mg/ml
bovine serum albumin (BSA; Sigma, Deisenhofen, Germany), and
hormones/growth factors as specified below. The medium was
stored at 4°C and prewarmed to 37°C immediately before reach-
ing the perfusion culture container.
Hormone and growth factor experiments
The culture medium was supplemented with basic fibroblast
growth factor (PBH, Hannover, Germany) at concentrations of
5.5 3 10212 M, 5.5 3 10211 M and 5.5 3 10210 M (equivalent to 0.1,
1 and 10 ng/ml; Table 1). Purified vascular endothelial growth
factor (VEGF164), a generous gift of Prof. Dr. H. Weich, GBF
Braunschweig, Germany, was added in a concentration of 1.25 3
10210 M (equivalent to 5 ng/ml). Hormones were applied alone or
in combination at the following concentrations: 1 3 1027 M
aldosterone (Ciba Geigy, Basel, Switzerland), 1 3 1029 M 1,25-
dihydroxyvitamin D3 (Biomol, Hamburg, Germany), 3.3 3 10
27 M
9-cis retinoic acid (Sigma). Furthermore, basic fibroblast growth
factor (bFGF) was applied in combination with 1 3 1027 M
aldosterone and 1029 M 1,25 dihydroxyvitamin D3. In another set of
experiments freshly prepared tissue was stationary preincubated for
three hours with 3.3 3 1027 M 9-cis retinoic acid prior to perfusion
culture with 5.5 3 10211 M bFGF (equivalent to 1 ng/ml). All culture
experiments were performed at least in triplicate.
Kinetic experiments
To analyze the time course of bFGF stimulation kinetic exper-
iments were carried out. Basic fibroblast growth factor (bFGF)
was applied for 1 to 13 days under perfusion culture conditions.
Tissue pieces were sampled daily and stored in liquid nitrogen
prior to further analysis.
In another set of experiments explants were stationary precul-
tured with various concentrations of bFGF (0.1 to 10 ng/ml) for
one day and further cultured with basic culture medium only for
13 days.
Immunohistological analysis
Following perfusion culture the explants were washed in basic
medium, placed in a drop of TissueTek O.C.T. 4583 Compound
(Miles, Elkhart, USA) and frozen in liquid nitrogen. Cortico-
medullary oriented sections of 8 mm thickness were cut with a
cryomicrotome (Micron, Heidelberg, Germany).
The fixation and incubation procedure for the detection of
antigens has been described in detail elsewhere [26]. In brief, a
solution of 4.2% paraformaldehyde (Merck, Darmstadt, Germa-
ny), 16% picric acid (Fluka, Buchs, Switzerland), 0.002% cobalt
chloride and 0.1% glutaraldehyde (Serva, Heidelberg, Germany)
in phosphate buffered saline (PBS; pH 7.2) was applied for
fixation. Then the sections were incubated in blocking buffer (0.1
M Tris-buffer, pH 7.4, 25% fetal calf serum, 1% NaCl, 1% Triton
X-100) for 45 minutes.
The monoclonal antibody EC1 [26] was used to detect endo-
thelial cells. EC1 is specific exclusively for rabbit endothelial cells.
Proliferating cells were labeled using the monoclonal antibody
Ki-67 [27]. Primary antibodies were applied as undiluted culture
supernatants overnight.
Biotin-conjugated donkey anti-mouse Ig antiserum (Dianova,
Hamburg, Germany) was used to detect bound primary antibody.
Finally, avidin conjugated with horseradish peroxidase (Vec-
tastain; Vector, Burlingame, CA, USA) was applied, and the
enzyme reaction was started by the addition of the substrate
solution (0.5 mg diaminobenzidine; Sigma; 0.1 M Tris, pH 7.4,
0.002% cobalt chloride, 0.04% nickel chloride, 0.012% H2O2).
The sections were embedded in DePeX (Serva) and analyzed with
a Zeiss Axiovert 35 microscope (Zeiss, Oberkochen, Germany).
Table 1. Stimulation of vessel development in renal explants
Medium supplement
Length of
supplement
application
Length of
culture
Single
endothelial
cells
Endothelium
arranged in
clusters
Vessel-like
structures
Without supplements 13d 13d 1 1 2
BSA, 0.1 mg/ml 13d 13d 1 1 2
bFGF, 5.5 3 10212 2 5.5 3 10210 M 13d 13d 2 2 2
bFGF, 5.5 3 10212 2 5.5 3 10210 M 1d 14d 1 1 2
Aldosterone, 1027 M 13d 13d 1 2 (1)
Vitamin D3, 10
29 M 13d 13d 1 2 (1)
Aldosterone, 1027 M 13d 13d 1 2 11
1Vitamin D3, 10
29 Ma
9-cis Retinoic acid, 3.3 3 1027 M 3h 13d 1 2 11
VEGF, 1.25 3 10210 Ma 13d 13d 1 2 11
bFGF, 5.5 3 10211 M 1Aldosterone 1 Vitamin D3
a 13d 13d 1 2 11
9-cis Retinoic acid 3h 1 2
1bFGF, 5.5 3 10211 M 13d 13d 11
bFGF 5.5 3 10211 M 13d 13d 1 2 (1)
1VEGF, 1.25 3 10210 M
Symbols are: 2 not detectable, 1 detectable, (1) network partially preserved, 11 network completely preserved. Abbreviations are: bFGF, basic
fibroblast growth factor; BSA, bovine serum albumin; VEGF, vascular endothelial growth factor. Renal explants were cultured for 1 to 14 days under
continuous medium perfusion. The serum-free culture medium was supplemented with various hormones or growth factors.
a Data published previously [28].
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Agfa Pan 25 film (Agfa, Leverkusen, Germany) was used for
photographic documentation.
Specificity controls
In order to ensure the specificity of the antibody labeling
different controls were included in the experiments. Pre-immune
serum as well as irrelevant primary antibodies were applied.
Furthermore, control sections were incubated with the detect-
ing antibody and the enzyme complex alone. None of these
control sections showed any positive antibody labeling of the
vessels.
A commercially available endothelium-specific antibody
(PAL-E; Progen, Heidelberg, Germany; [28]) was applied to
verify the absence of endothelial cells in bFGF stimulated ex-
plants.
Evaluation of cell proliferation
To determine the amount of cell proliferation, longitudinal
sections of cortex explants were probed with the monoclonal
antibody Ki-67, which recognizes a nuclear antigen specifically
expressed by proliferating cells [27]. Proliferating cells were
observed within all parts of the explants, but featured an inhomo-
geneous distribution. Therefore, we determined the labeled area
of the section instead of counting single cells (Table 2). Area
measurements were performed on digitized video images with the
image-processing program SOM 462 (BioRad, Munich, Germa-
ny). Proliferation activity in the tissue explants is expressed by the
percentages of the Ki-67 labeled areas. At least three explants
were analyzed for each experiment, and six sections of each
explant were evaluated. Percentages of labeled areas 1/2 SDs are
given in Table 2.
RESULTS
Culture strategy
To investigate the cellular interactions during renal vessel
development a tissue culture model was used. Tissue explants
were prepared from neonatal rabbit kidneys by a microsurgical
method [25]. Proteases were not applied, leaving the natural
Table 2. Cell proliferation after growth factor and hormone application
Cell proliferation was detected by incubation of explant sections with
the monoclonal antibody Ki-67. The Ki-67 antigen is expressed by all
proliferating cells. To measure the decrease of cell proliferation, the
percentage of Ki-67 labeled section area has been determined. At least 3
explants per experiment and 6 sections per explant have been analyzed.
The standard deviation of the mean is indicated.
Controls: To determine the amount of proliferating cells within the
nephrogenic zone, section of the neonatal kidney has been analyzed.
Explants cultured for 13 days in the presence of 0.1% bovine serum
albumin were used as control for tissue cultured without growth factor or
hormone supplement.
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Fig. 1. Endothelial cells and cell streaks as well as vessels within the nephrogenic zone of the neonatal kidney are shown, which have been labeled by
the monoclonal antibody EC1 (a). The monoclonal antibody EC1 was used for the detection of vessels of different developmental stages. The developing
vascular network showed a high degree of regular spatial organization. Endothelial cell streaks (arrowheads) running parallel to each other towards the
organ capsule (CF) were frequently observed. Abbreviations are: A, collecting duct ampulla; G, glomerulus (magnification 3175). (b) Proliferating cells
of the nephrogenic zone were detected by the monoclonal antibody Ki-67, which recognizes a nuclear antigen specifically expressed by proliferating cells.
S-shaped bodies (arrow) and collecting duct ampullae were intensively labeled. Beyond the nephrogenic zone the number of proliferating cells decreased
markedly (magnification 3175). (c) The nephrogenic zone was prepared and put in culture. The explants were cultured under continuous medium flow
(1 ml/hr) for 13 days. Endothelial cell clusters labeled by EC1 were detected within explants which were cultured with basal medium alone (IMDM, 0.1%
bovine serum albumin). While the endothelial antigen EC1 was continuously expressed in the absence of hormones and growth factors, the regular
organization of the developing vascular network was not preserved. Abbreviations are: CF, fibrous organ capsule; E, collecting duct epithelium; T, cross
section of tubule (magnification 3140). (d) A considerable number of proliferating cells were labeled by Ki-67 within explants cultured for 13 days with
basal medium alone. Abbreviation is: CF, fibrous organ capsule (magnification 3140). (e) No endothelial cells were detectable within renal explants
which were cultured for 13 days in the presence of bFGF. All endothelial structures observed within the nephrogenic zone (a) have disappeared. Tubular
structures were absent as well. The tissue was of homogeneous composition (magnification 3140). (f) Proliferating cells could not be detected
after 13 days of bFGF stimulation. The anti-proliferative effect of bFGF was underlined when the thickness of these explants was compared with
other samples. bFGF-treated explants were considerably thinner (150 mm) than tissues cultured in the presence of BSA (c) or hormones (300 mm)
(magnification 3140). (g) Kinetics of endothelial cell disappearance. At culture day 7 a few endothelial cells were detected in bFGF-stimulated
tissue. A regular spatial organization of the endothelial cell streaks was not observed at this time point (magnification 3140). (h) Cell proliferation
decreased continuously, but some proliferating cells labeled by the monoclonal antibody Ki-67 were detected within this explant. Other samples
taken at culture day 7 already failed to show Ki-67 positive cells. Abbreviations are: CF, fibrous organ capsule; E, collecting duct epithelium
(magnification 3140).
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arrangement of the different tissue components and the organ-
specific extracellular matrix unchanged.
The tissue was cultured under permanent medium exchange.
Neither metabolites, nor paracrine factors can accumulate in the
culture container as long as the tissue is continuously supplied
with fresh medium. This perfusion culture method allows for the
complete omission of serum supplement to the culture medium
[29]. The influence of paracrine and endocrine growth and
differentiation factors on the development of the renal vessel
system could thus be analyzed without interference with unknown
serum components.
Tissue explants cultured with IMDM medium alone or in the
presence of 0.1% BSA showed no necrotic lesions even after 13
days (Fig. 1c and Table 1). In these explants the endothelial cells
were arranged in large clusters but not in vessel-like structures. The
typical three-dimensional structure of the developing renal vascular
network (Fig. 1a) [30] could only be preserved in the presence of the
growth and differentiation factors (Table 1 and Fig. 2).
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Modulation of renal vessel development by basic fibroblast
growth factor
From the reports of many authors we know that bFGF is an
angiogenic factor [14, 31]. In order to analyze the influence of
bFGF on renal vessel development, tissue explants were cultured
serum free in the presence of bFGF. The application of culture
medium supplemented with BSA and bFGF resulted in the
disappearance of vessel-like structures (Fig. 1e). The endotheli-
um-specific monoclonal antibody EC1 failed to label cell streaks
like those observed within the nephrogenic zone of the kidney
(Fig. 1a). Only few EC1-positive cells were detected within bFGF
incubated explants. The incubation of these explants with a
different endothelium-detecting antibody (PAL-E) confirmed this
result (data not shown). PAL-E did not label any cells within these
explants.
Another unexpected observation was that explants cultured
with bFGF in a concentration range from 5 3 10212 to 5 3 10210
M were considerably thinner (less than 200 mm; Fig. 1 e, g) than
those cultured with the hormone combination aldosterone/vita-
min D3 or with retinoic acid (Fig. 2, 300 to 500 mm). Furthermore,
the bFGF-treated tissue was of a homogeneous composition. The
typical collecting duct ampullae or renal tubules that were found
in explants cultured with BSA (Fig. 1c) or hormones (Fig. 2) were
not observed. However, a single collecting duct epithelium always
completely covered the side of the explant which was not coated
by the fibrous organ capsule.
Time course of endothelial cell disappearance
In another set of experiment the time course of endothelium
disappearance was analyzed. Explants cultured for 1 to 13 days
under the influence of bFGF were sectioned and incubated with
EC1 and the proliferation marker Ki-67. After one day of
stimulation with bFGF no morphological difference could be
detected between the developing vascular network and freshly
prepared explants. After seven days of culture in the presence of
bFGF the vessels tended to disappear, and the endothelial cells
formed small clusters (Fig. 1g). Extinction of endothelial cells was
completed after 13 days (Fig. 1e). Not even EC 1-positive cell
clusters, like those found in explants cultured with BSA (Fig. 1c)
were detectable anymore.
To investigate whether the disappearance of endothelial cells
was due to the permanent application of bFGF, some explants
were preincubated for 24 hours with bFGF and then perfusion
cultured with basic medium only for 13 days. These explants were
approximately 300 mm thick and were characterized by endothe-
lial cell clusters (Table 1). These samples could not be distin-
guished from explants cultured with BSA alone. Even after the
application of higher concentrations of bFGF (5 3 10210 M) no
complete extinction of endothelial cells from the cultured tissue
was observed. The spatial organization of the developing vascular
network was disturbed in the same way as in control explants
cultured with BSA alone. We have to conclude that the extinction
of endothelial cells from the explant was coupled to the continu-
ous presence of bFGF.
Stimulation of renal vessel development by retinoic acid
Retinoic acid is a known potent differentiation factor and an
important factor for kidney development [18]. To investigate
whether the hormone is directly involved in renal vessel forma-
tion, it was tested in our tissue culture system. Retinoic acid was
applied for 1 to 24 hours. This short stimulus was sufficient to
initiate a tremendous broadening of vessel-like structures in the
explants (Fig. 2a and Table 1). Moreover, the regular spatial
organization of the vascular network was preserved after 13 days
of culture. Broad endothelial cell streaks showed an orderly
spatial distribution. Retinoic acid stimulated explants were char-
acterized by numerous tubular structures that were closely sur-
rounded by endothelial cell streaks.
Development of the renal vascular network in the presence of
growth and differentiation factors combined with basic
fibroblast growth factor
Further experiments were performed to investigate whether the
inhibitory effect of bFGF could be overcome by other growth and
differentiation factors. The bFGF was applied in combination
with retinoic acid, with aldosterone and vitamin D3, or with
VEGF (Table 1). These substances have been used successfully
for the stimulation of renal vessel development under serum free
perfusion culture conditions [26, 27].
All of these supplements were able to stimulate vessel devel-
opment in the presence of bFGF. When bFGF was combined with
retinoic acid or aldosterone/vitamin D3, vessel-like structures in
general were thinner than in the explants that were cultured
without bFGF. This effect was prominent in retinoic-acid-stimu-
lated tissue (Fig. 2c). Small vessel-like structures were detected in
these explants, while retinoic acid alone led to a considerable
broadening of the endothelial cell streaks. When both retinoic
acid and bFGF were applied, smaller vessel-like structures were
detected. The three-dimensional structure of the developing
vessel network was also preserved.
Another interesting result of these experiments was the detec-
tion of another endothelial cell generation. Only in explants
stimulated with bFGF and retinoic acid, a new generation of
endothelial cell streaks was detected (Fig. 2c). These cells were
located adjacent to the fibrous organ capsule. They were sepa-
rated from the other vascular elements by a zone (30 to 50 mm) of
unlabeled cells. These explants showed a large number of tubules
and collecting duct ampullae. A single collecting duct epithelium
covered one side of the explant, while the other side was covered
by the fibrous organ capsule. A homogeneous composition of the
explant as seen after bFGF stimulation alone was never observed.
Vascular endothelial growth factor (VEGF) is produced in the
maturing kidney [1], and the developing renal vessels are stimu-
lated by this angiogenic factor (Table 1) [29]. When VEGF and
bFGF were applied in combination, the extinction of endothelial
cells from the explant could be prevented. Endothelial cells
arranged in clusters or streaks could be detected (Fig. 2e) after 13
days of culture with VEGF and bFGF. However, an orderly
network arrangement of endothelial cells like that abundant after
hormone treatment was not found in these explants.
Modulation of cell proliferation
It has been mentioned above that bFGF treated explants were
considerably thinner than hormone or VEGF stimulated tissue.
Freshly prepared explants were 100 to 150 mm thick. Following
bFGF application no explants were obtained that were thicker
than 200 mm (Fig. 1e), while hormone stimulated explants in
general were thicker than 300 mm (Fig. 2). In order to investigate
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Fig. 2. Stimulation of vessel development by basic fibroblast growth factor (bFGF) combined with retinoic acid and vascular endothelial growth factor
(VEGF). Explants cultured for three hours with 9-cis retinoic acid and subsequently with basic medium for 13 days were characterized by broad
endothelial cell streaks (a), which enclose tubular structures (T). Proliferating cells (b) were detectable even after 13 days of culture. The combination
of a preculture of the explants with retinoic acid and subsequent perfusion culture in the presence of bFGF (5.5 3 10211 M) resulted in considerably
smaller endothelial cell streaks (c). Beneath the fibrous organ capsule another generation of endothelial cells (arrow) could be detected. Few
proliferating cells (d) could be observed after 13 days. When explants were treated with VEGF and bFGF the inhibitory effect of bFGF could be
overcome as well (e). However, the endothelial cells were arranged in clusters, not in form of cell streaks (f). Some proliferating cells were detectable
within these explants after 13 days of culture. Abbreviations are: CF, fibrous organ capsule; T, cross section of tubule. The magnification for all panels
was the same: 3140.
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whether the thickening of the explants correlates with the rate of
cell proliferation, sections were incubated with the proliferation
marker Ki-67 [27].
Within the nephrogenic zone of the cortex of the neonatal
kidney nearly 50% of the section area was labeled by the antibody
(Fig. 1b and Table 2). Proliferating cells within S-shaped bodies,
collecting duct ampullae and mesenchyme were detected by
Ki-67. Beyond the nephrogenic zone a remarkable decrease of cell
proliferation was observed.
In cortex explants proliferating cells could be detected through-
out the whole culture period (Fig. 1 d, f and Fig. 2 b, d, f), but the
number of proliferating cells decreased considerably after the first
seven days of culture (Fig. 1h and Table 2). The decrease of the
cell proliferation clearly depended on the medium supplements.
A sharp decrease of proliferation was detected after seven days
of culture with BSA. Less than 5% of the section area showed
Ki-67 labeling (Table 2), but proliferating cell could be detected
even after 13 days (3% of the section area; Fig. 1d).
Basic fibroblast growth factor-stimulated explants cultured for 7
and 13 days were analyzed for Ki-67 labeled cells. Cell prolifera-
tion decreased, but was still detectable in some of these explants
on day 7 (Fig. 1h and Table 2). Then proliferation ceased
completely and was not initiated again by day 13 of culture.
After application of retinoic acid cell proliferation decreased
but could be detected during the whole culture period (Fig. 2b and
Table 2). Retinoic acid-stimulated explants were approximately
400 mm thick. Compared with VEGF or aldosterone/vitamin D3
stimulated tissue these explants showed the highest percentage of
proliferating cells (5.7% labeled section area) after 13 days of
culture. When VEGF or aldosterone and vitamin D were applied
more than 10% labeled section area was measured at culture day
7, but then the proliferation rate decreased, and at culture day 13
less than 5% labeled area was found in tissue sections of these
explants. The combined application of VEGF and bFGF did not
result in a further reduction of the proliferation rate (Table 2).
When retinoic acid or aldosterone/vitamin D3 were applied in
combination with bFGF a significant reduction of cell prolifera-
tion took place (Table 2). The inhibitory effect of bFGF was most
obvious when retinoic acid and bFGF were combined. While 5.7%
of the section area was marked by Ki-67 when retinoic acid was
applied alone, it was reduced to 1.8% when bFGF was added.
DISCUSSION
Known functions of basic fibroblast growth factor and its role
in renal vessel development
The basic fibroblast growth factor (bFGF) fulfills a multitude of
different functions in a variety of cells during organogenesis.
bFGF has been described as a mitogen, a chemoattractant and a
differentiation-promoting agent [10, 14, 31]. These various effects
are mediated by different receptors and receptor isoforms [32]
with tyrosine kinase activity. The receptor specificity of the
different forms of FGFs is low. bFGF, for example, binds to three
different FGF receptors with comparable affinity [32]. The ex-
pression of the FGF receptors is developmentally regulated [33,
34]. Remarkably, FGF receptor 1 is expressed mainly by the
epithelia of the developing kidney, while FGF receptor 2 is
restricted to the mesenchyme. In contrast, FGF receptors have
not been detected on endothelial cells up to now [34], but are
expressed by all renal epithelial cells during development [14].
bFGF has been discussed as an essential factor for epithelial-
mesenchymal induction during the amphibian development [35].
However, it is not known whether this is the function of bFGF
during nephron induction.
On the other hand, bFGF is a potent angiogenic factor stimu-
lating the proliferation and migration of endothelial cells [31]. In
view of these data the results of bFGF application in the renal
tissue culture system were rather surprising. The application of
biologically active bFGF in a complex tissue environment and
under serum free culture conditions resulted in the obvious
extinction of endothelial cells, visualized by the homogeneous
tissue composition as well as the failure of different endothelial
detecting antibodies to label cells in the tissue explant. As shown
in the present investigation this process followed a set time course
and depended on the permanent presence of bFGF (Table 1).
The disappearance of endothelial cells could not be induced by a
single dose of bFGF. The inhibitory effect of bFGF is further
illustrated by the reduced thickness of bFGF-stimulated explants,
and the complete cessation of cell proliferation after 13 days.
bFGF was the only tested substance which completely abolished
cell proliferation (Table 2). Even control explants treated with
basic medium alone showed proliferating cells after 13 days.
Consequently, explants stimulated with bFGF were considerably
thinner than hormone stimulated tissues. In our serum-free tissue
culture model, bFGF showed an anti-proliferative effect. More-
over, bFGF even caused the complete extinction of endothelial
cells when permanently applied.
It has already been reported that the influence of a growth
factor on the cellular reaction might depend on the test system
used [31]. This may prove important especially in tissue pieces
with a complex composition which were treated with bFGF under
serum free culture conditions. We may assume that other cellular
components than endothelial cells reacted to bFGF stimulation,
eventually inducing the release of inhibitory substances. The
mesenchyme itself or the epithelium of the collecting ducts are
likely candidates for a direct bFGF stimulation, because these
cells have been shown to express FGF receptors [33, 34]. Reports
of a tight cooperation between mesenchymal and epithelial cells
of the nephrogenic zone during renal organogenesis are numer-
ous [12, 36]. Recently, the production of the angiogenic factor
VEGF by the collecting duct epithelium was described [37].
However, for proper organ development not only mitogenic
signals are required. On the contrary, cell proliferation has to be
tightly regulated and terminated. This could be achieved by
contact inhibition as well as by soluble inhibitors. Whether bFGF
itself inhibits cell proliferation or whether it induces the produc-
tion of inhibitory molecules has to be investigated.
The stimulating effect of endocrine and paracrine factors on
developing renal vessels can be modulated by bFGF
As shown in the present study, bFGF alone does not stimulate
proliferation of the renal endothelium or the preservation of its
regular spatial organization. The combined application with
VEGF promoted endothelial proliferation but was not sufficient
to preserve the spatial organization of the developing vascular
network completely (Table 1). It is concluded that other mole-
cules in addition to bFGF and VEGF must be involved in renal
vessel development.
Retinoids are potent stimulators of differentiation [18]. An
expression of retinoid receptors in the kidney has not been
Kloth et al: Modulation of renal vessel development976
reported yet. However, transgenic mice expressing double null
mutations of retinoid receptors showed severe kidney defects [20].
Retinoic-acid-deficient diets during pregnancy lead to malforma-
tions of the kidney [19]. In contrast, the application of high
concentrations of retinoic acid during pregnancy caused urogen-
ital defects [38]. Thus, a defined retinoid concentration seems to
be required for proper development of the kidney.
Recently, it was reported that the incubation of kidney rudi-
ments with retinoic acid derivatives leads to a considerable
stimulation of organ growth by collecting duct branching [39].
These data are confirmed by the present experiments. The
proliferation of endothelial cells in the nephrogenic zone is
strongly stimulated by retinoic acid. The three-dimensional orga-
nization of the vascular network within this tissue region is
preserved, while the vessel-like structures are considerably broad-
ened. Thus, retinoic acid as well as the hormone combination
aldosterone/vitamin D3 [29] provide a sufficient stimulus for
endothelial proliferation and for the preservation of the spatial
organization of the developing vascular network.
The zone between the tips of the growing collecting ducts and
the fibrous organ capsule is occupied by mesenchymal cells and
vessel precursors [40]. Within this region new nephron genera-
tions and the dichotomous branching of the collecting duct
ampullae are initiated by reciprocal induction of mesenchyme and
embryonic collecting duct epithelium [36]. While VEGF and
aldosterone in combination with vitamin D3 mainly supported
vessel broadening and elongation, a further generation of endo-
thelial cell streaks was observed within the nephrogenic zone after
stimulation of renal explants with retinoic acid and bFGF. Thus,
these molecules did not only stimulate proliferation of the endo-
thelial cells which were present in the explant at the time of
excision from the organ, but they also supported the formation of
new vessel generations. These vessels were found predominantly
within mesenchymal tissue regions. Whether this finding indicates
the formation of endothelial cells from mesenchyme [41] or a
sprouting from existing vessels remains to be elucidated.
The application of retinoic acid alone induced an enlargement
of the endothelial cell streaks. The combination of retinoic acid
with bFGF resulted in considerably thinner vessels and a preser-
vation of the spatial organization of the developing vessel net-
work. It is still unknown whether these substances act directly on
endothelial cells or whether they induce the production of regu-
lating factors by other tissue components as epithelial cells or
mesenchyme [42, 43]. With respect to bFGF, we assume a
morphogenic rather than a mitogenic function during kidney
development. We may speculate that this factor could induce the
production of an antagonist for angiogenic factors, thus balancing
mitogenic stimuli. Whether this is the physiological function of
bFGF in the kidney will be the focus of further experiments.
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